Abstract. The aim of the present study was to investigate the cardioprotective effect of tanshinone IIA and the underlying molecular mechanisms. An in vitro model of oxidative stress injury was established in cardiac H9c2 cells, and the effects of tanshinone IIa were investigated using cell viability, reverse transcription-quantitative polymerase chain reaction and western blotting assays. The results demonstrated that tanshinone IIA protects H9c2 cells from H 2 O 2 -induced cell death in a concentration-dependent manner, via a mechanism involving microRNA-133 (miR-133), and that treatment with TIIA alone exerted no cytotoxic effects on H9c2. In order to further elucidate the mechanisms underlying the actions of TIIA, reverse transcription-quantitative polymease chain reaction and western blot analysis were performed. Reductions in miR-133 expression levels induced by increasing concentrations of H 2 O 2 were reversed by treatment with tanshinone IIA. In addition, the inhibition of miR-133 by transfection with an miR-133 inhibitor abolished the cardioprotective effects of tanshinone IIA against H 2 O 2 -induced cell death. Furthermore, western blot analysis demonstrated that tanshinone IIA activated Akt kinase via the phosphorylation of serine 473. Inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway by pretreatment with the PI3K specific inhibitors wortmannin and LY294002 also eliminated the cardioprotective effects of tanshinone IIA against H 2 O 2 -induced cell death. Western blot analysis demonstrated that H 2 O 2 -induced reductions in B cell lymphoma 2 (Bcl-2) expression levels were reversed by tanshinone IIA. In addition, the effect of tanshinone IIA on Bcl-2 protein expression level in an oxidative environment was suppressed by a PI3K inhibitor, wortmannin, indicating that tanshinone IIA exerts cardioprotective effects against H 2 O 2 -induced cell death via the activation of the PI3K/Akt signal transduction pathway and the consequent upregulation of Bcl-2. In conclusion, the present study demonstrates that TIIA is able to protcet H9c2 cells from oxidative stress-induced cell death through signalling pathways involving miR-133 and Akt, and that tanshinone IIA is a promising natural cardioprotective agent.
Introduction
Danshen (root of Salviae miltiorrhizae) is widely prescribed in traditional Chinese medicine (1, 2) , and tanshinone IIA (C 19 H 18 O 3 ) may be obtained from it by extraction (3, 4) . It has been demonstrated that tanshinone IIA exerts a variety of biological activities in the cardiovascular system, serving as an antioxidant and anticoagulant, and possesses anti-atherosclerotic, anti-apoptotic and anti-hypertrophic properties (5) (6) (7) (8) (9) . Accumulating evidence suggests that tanshinone IIA reduces the area of ischemic infarction and improves cardiac function (7, 10) . Although the cardioprotective effects of tanshinone IIA have been investigated for numerous years, the underlying molecular mechanisms remain elusive.
MicroRNAs (miRNAs) are small endogenous ~22 nucleotide noncoding RNAs. They regulate post-transcriptional gene expression by complementing the 3'-untranslated regions of their target mRNAs, resulting in mRNA degradation or the inhibition of translation (11, 12) . Due to their involvement in the regulation of gene expression, miRNAs serve an important role in cardiac function, including the conductance of electrical signals, heart muscle contraction, development and morphogenesis; miRNAs are also involved in the proliferation and apoptosis of cardiomyocytes, cardiac hypertrophy and heart failure (13) (14) (15) . In particular, a number of studies suggest that miRNA-133 (miR-133) serves an important role in the cardiovascular system (15) (16) (17) . In the present study, the role of miR-133 in the myocardial protective effect of tanshinone IIA against hydrogen peroxide (H 2 O 2 )-induced induce cell death was investigated.
Akt is a vital regulator of cell survival that antagonizes apoptosis; when activated, Akt phosphorylates its downstream targets, contributing towards its inhibitory effect Tanshinone IIA protects H9c2 cells from oxidative stress-induced  cell death via microRNA-133 upregulation and Akt activation on the apoptosis of cardiomyocytes induced by multiple stimuli, including H 2 O 2 (18, 19) . Numerous putative downstream targets have been identified that may contribute to the anti-apoptotic effects of Akt, including the transcriptional nuclear factor (NF)-κB and B-cell lymphoma-2 (Bcl-2) (18). In the current study, the role of the phosphatidylinositol 3-kinase (PI3K)/Akt/NF-κB/Bcl-2 axis in the myocardial protection effect of tanshinone IIA against oxidative stress-induced cell death was investigated. 
Materials and methods

Materials
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA samples were extracted using TRIzol reagent (Thermo Fisher Scientific, Inc.) from cultured cells. miR-133 expression levels were quantified using the Bulge-Loop miRNA wRT-PCR Primer Set (Guangzhou RiboBio Co., Ltd.) in conjunction with RT-qPCR using SYBR Green I dye (Beijing TransGen Biotech Co., Ltd., Beijing, China). U6 (included in the Bulge-Loop miRNA qRT-PCR Primer Set) was used as an internal control. The relative expression of miR-133 was calculated and normalized to U6 using the comparative Cq method. Relative expression intensity values were calculated as 2 -ΔΔCq (16) . The RT-qPCR was performed using the SYBR green method with an Applied Biosystems 7500 Real-Time PCR System (Thermo Fisher Scientific, Inc.).
Cell transfection with miR-133 mimic or miR-133 inhibitor.
Transfection was performed using Effectene Transfection Reagent, according to the protocol recommended by the manufacturer (Qiagen GmbH, Hilden, Germany). In brief, cells were seeded into 96-well plates 1 day prior to transfection. Next, the cells were transfected with an miR-133 mimic or an miR-133 inhibitor at a final concentration of 50 nM using Effectene Transfection Reagent, in accordance with the manufacturer's instructions.
Western blot analysis. Following treatment, H9c2 cells were harvested and lysed in radioimmunoprecipitation assay buffer (Applygen Technologies, Inc., Beijing, China). The whole cell lysates were then resolved by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a 0.4 µm-polyvinylidene difluoride (PVDF) membrane (EMD Millipore, Billerica, MA, USA). After blocking in 5% non-fat milk for 2 h at room temperature, the PVDF membranes were probed with primary antibody overnight. Following a 30-min wash with Tris-buffered saline containing 0.1% Tween-20 (TBST), the membranes were incubated with HRP-conjugated secondary antibody (1:10,000) for 1 h at room temperature. The membranes were then washed with TBST for 30 min and visualized using an Enhanced Chemiluminescence detection kit (Merck Millipore, Darmstadt, Germany). β-actin served used as an internal control.
Statistical analysis. Data were analyzed using SPSS version 13.0 software (SPSS, Inc., Chicago, IL, USA) and presented as the mean ± standard deviation. Numeric variables were compared using one-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference. induced H9c2 cell death in a concentration-dependent manner (Fig. 1A) , while tanshinone IIA displayed no cytotoxic effect on H9c2 cells at any concentration studied (Fig. 1B) . In addition, the exposure of H9c2 cells to tanshinone IIA significantly suppressed the cytotoxic effect of H 2 O 2 in dose-dependent manner (P<0.05; Fig. 1C ), confirming the previously reported cardioprotective effects of tanshinone IIA (21) (22) (23) (24) .
Results
Effect of tanshinone
Involvement of miR-133 in the mechanism of action of tanshinone IIA. In order to study the role of miR-133 in the function of tanshinone IIA, miR-133 expression levels in H9c2 cells were determined using RT-qPCR following treatment with tanshinone IIA and/or H 2 O 2 (Fig. 2) . The results demonstrated that H 2 O 2 decreases the expression of miR-133 in a dose-dependent manner. However, the downregulation of miR-133 by H 2 O 2 was reversed by treatment with tanshinone IIA (Fig. 2) , indicating that miR-133 is involved in the myocardial protective effect of tanshinone IIA. To verify this, an miR-133 mimic and miR-133 inhibitor were transfected into H9c2 cells to potentiate and suppress miR-133, respectively. As presented in Fig. 3 , the miR-133 mimic alleviated oxidative injury in H9c2 cells. Furthermore, the myocardial protective effect of tanshinone IIA was inhibited by the miR-133 inhibitor (Fig. 3) .
Role of Akt activation in the mechanism of action of tanshinone IIA. The results of western blot analysis demonstrated that treatment with tanshinone IIA promoted Akt phosphorylation at the amino acid serine 473 in a concentration-dependent manner (Fig. 4A) , indicating that the PI3K/Akt signaling pathway was activated. Blocking the signaling pathway using the PI3K-specific inhibitors wortmannin and LY294002 eliminated the ability of tanshinone IIA to protect H9c2 cells from oxidative injury (Fig. 4B) . 
A B C
Role of Bcl-2 expression in the mechanism of action of tanshinone IIA. Expression of Bcl-2 is regulated by the PI3K/Akt/NF-κB signaling pathway (25) . Since tanshinone IIA was observed to activate PI3K/Akt signaling in H9c2 cells (Fig. 4A ) and protect H9c2 cells from oxidative stress-induced death (Fig. 4B) , activation of the PI3K/Akt signaling pathway by tanshinone IIA appears to be instrumental to the survival of H9c2 cells. This was further investigated by evaluating the expression of Bcl-2. Western blotting results demonstrated that H 2 O 2 decreased the expression of Bcl-2 in H9c2 cells in a time-dependent manner, whereas tanshinone IIA increased Bcl-2 expression in H9c2 cells ( Fig. 5A and B) . Furthermore, the results demonstrated that the downregulation of Bcl-2 expression by H 2 O 2 in H9c2 cells is reversed by treatment with tanshinone IIA (Fig. 5C ). However, this reversion process is inhibited by the PI3K-specific inhibitor wortmannin (Fig. 5C ), indicating that tanshinone IIA upregulates Bcl-2 expression by activating the PI3K/Akt signaling pathway.
Discussion
Tanshinone IIA, one of the most abundant tanshinones, exhibits a variety of cardiovascular activities, including vasorelaxation, and protection against ischemia-reperfusion injury and the effects of antiarrhythmia (4, 7, 26) . A number of studies have demonstrated that tanshinone IIA increases coronary blood flow and protects the heart against cardiac injury (7, 10, 22, 23, (27) (28) (29) (30) (31) . The molecular mechanisms underlying the cardioprotective effects of tanshinone IIA were investigated in the present study. The results demonstrated that tanshinone IIA protects H9c2 cells from H 2 O 2 -induced cell death, which confirms the cardioprotective effect of tanshinone IIA in the oxidative stress injury model in vitro.
In addition, the current study provides evidence that miR-133, Akt activation and Bcl-2 are involved in the cardioprotective effects of tanshinone IIA against oxidative stress-induced cell death. miRNAs serve an important role in the proliferation and apoptosis of cardiomyocytes, cardiac hypertrophy and heart failure (13) (14) (15) . Previous studies have demonstrated that muscle-specific miRNAs (miR-1 and miR-133) are important regulators of myogenesis (32) . In addition, their upregulation or downregulation may influence the pathogenesis of cardiac diseases (33) (34) (35) . He et al reported that miR-133 provides protection in myocardial ischemic post-conditioning via the regulation of the initiator caspase, caspase-9 (36). The PI3K signaling pathway controls cardiomyocytes survival and function (37) . The downstream effects of the PI3K signaling pathway are primarily mediated by Akt, a serine/threonine kinase, to coordinate a variety of intracellular signals, and thereby regulate cell proliferation and survival (38) . Activation of the PI3K/Akt signaling pathway has been shown to protect the myocardium from myocardial injury and prevent the apoptosis of cardiomyocytes (38) . In order to explore whether the protective effects of tanshinone IIA against H 2 O 2 -induced cell death are associated with the PI3K/Akt signaling pathway, the current study investigated the effects of tanshinone IIA on the phosphorylation of Akt and the effects of PI3K inhibition on the cardioprotective effects of tanshinone IIA against H 2 O 2 -induced cell death. The results demonstrated that tanshinone IIA increased the phosphorylation of Akt at serine 473 in a dose-dependent manner. In addition, the blockade of Akt phosphorylation with a PI3K inhibitor (wortmannin or LY294002) eliminated the cardioprotective effects of tanshinone IIA against H 2 O 2 -induced cell death, suggesting that tanshinone IIA exerts cardioprotective effects against oxidative stress-induced cell death via the activation of the PI3K/Akt signaling pathway.
The PI3K/Akt signaling pathway can upregulate the expression of anti-apoptotic genes (18, 19) . For example, Akt activates inhibitor of κB (IκB) kinases (IKKs), resulting in the activation of NF-κB (18, 19) , its translocation to the nucleus and the transcription of anti-apoptotic genes, such as BCL-2 (39, 40) . In the present study it was observed that H 2 O 2 decreased the expression of Bcl-2 in a time-dependent manner, while tanshinone IIA increased Bcl-2 expression in a time-dependent manner. In addition, the reduction of Bcl-2 expression induced by H 2 O 2 was attenuated by tanshinone IIA, and this effect was suppressed by pre-treatment with the PI3K inhibitor, wortmannin.
In conclusion, the results from the present study suggest that tanshinone IIA exerts its cardioprotective effects against H 2 O 2 -induced cell death by upregulating the expression of Bcl-2 via the activation of the PI3K/Akt signaling pathway. In addition, tanshinone IIA is able to protect H9c2 cells from oxidative stress-induced cell death. Tanshinone IIA may potentially be used to treat heart diseases involving oxidative stress; however, further studies are required in order to define and clarify the rationale for its clinical use.
